1. INTRODUCTION {#sec1}
===============

Neurotrophic factors regulate growth, proliferation, differentiation, and maturation of cells, but also cell migration, cell metabolism and apoptotic cell death \[[@r1], [@r2]\]. Neurotrophins are members of the family of neurotrophic factors and include nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and NT-4/5. Neurotrophins play a pivotal role in proper brain development and in mediating synaptic plasticity during adulthood \[[@r3]\]. NGF is the first and best characterized neurotrophin, expressed both in the central (CNS) and peripheral nervous system (PNS) \[[@r2], [@r4], [@r5]\], while BDNF is more widely distributed in the CNS \[[@r6]-[@r8]\]. The biological effects of these two neurotrophins are mediated through the activation of different members of the tropomyosin-related kinase (Trk) family also known as high-affinity receptors: NGF binds to TrkA while BDNF activates TrkB. Once activated, these receptors stimulate several intracellular signalling mechanisms, leading to different cellular responses and promoting survival, growth, differentiation and maintenance of both neuronal and non-neuronal cells. Furthermore, both neurotrophins are able to bind and activate the p75 neurotrophin receptor, p75^NTR^, (the neurotrophins low-affinity receptor), a member of the tumor necrosis factor receptor superfamily \[[@r6]-[@r8]\]. It is known that during central nervous system development, the expression of neurotrophins and their receptors are regulated and mainly localized in the hippocampus and cortex, brain areas involved in neuronal plasticity associated with learning and memory mechanisms \[[@r9]\], including brain-related disease \[[@r10]\]. During fetal growth, abnormalities in NGF and/or BDNF synthesis could deregulate CNS development, and in particular the limbic system development, with long-lasting effects on neuronal connections. These alterations in hippocampus and cortex development and in NGF/BDNF levels could be associated with the vulnerability to neuropsychiatric disorders. There are several epigenetic variables that can modify neuronal activity and, in this context, ethanol exposure certainly exerts an important modulation in the genetic expression of growth factors \[[@r11], [@r12]\]. Furthermore, it has been suggested that alcohol-neurotrophin interaction during development could contribute to the deleterious effects of prenatal alcohol exposure on neuroplasticity, learning and memory \[[@r3]\].

Several lines of evidence in the last years have highlighted that alcohol exposure during development may impair neurotrophic factors production and the expression of their receptors \[[@r13]-[@r20]\]. The most important neurotrophins involved in ethanol-induced toxicity are NGF and BDNF and their levels are known to be disrupted in the brain and periphery during acute/chronic alcohol consumption \[[@r13], [@r14], [@r21], [@r22]\]. Ethanol exposure has been demonstrated to alter the expression of neurotrophins and their receptors as well as the expression of their downstream signalling proteins. In particular, alcohol inhibits the expression of endogenous extracellular signal-regulated kinase (ERK) and the phosphatidylinositol-3-kinase (PI3K) \[[@r23]-[@r25]\]. Furthermore, Heberlein and colleagues demonstrated possible links between the epigenetic modulation of NGF and BDNF, the serum levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) and the symptomatology of alcohol dependence \[[@r26]\]. In particular, they showed an increase in NGF and IL-6 serum levels following alcohol consumption \[[@r27], [@r28]\] as well as an association between BDNF, TNF-α serum levels and the history of alcohol consumption \[[@r28], [@r29]\], suggesting that changes in the methylation of neurotrophins genes may contribute to the development of alcohol dependence by affecting relevant downstream signalling cascades \[[@r26]\].

2. The Pathophysiology of Prenatal Alcohol Exposure {#sec2}
===================================================

From ancient times it has been reported the possibility that drinking can cause fetal harm. According to a legend, Vulcan was born lame because Jupiter was drunk during conception. Hippocrates argued that parental drunkenness is the cause of the weakness of their children. In Carthage, there was a law that forbade the couple to drink alcohol on the day when they had to consummate the marriage.

Recommendations for women to not drink during pregnancy are already in the Bible, while, in more recent times, this problem began to be mentioned in medical journals, from the seventeenth century onwards. However, only in the last fifty years it has come to some awareness that children of alcoholic women who continue to drink even in pregnancy may have a variety of problems, including birth defects and neurological and cognitive disorders, closely related to a teratogenic action of alcohol.

Children of alcoholics, with particular and recurrent morphological and cognitive features have been described first in France and then in the United States \[[@r30], [@r31]\]. In 1973, Jones and Smith \[[@r32]\] coined the term Fetal Alcohol Syndrome (FAS) to indicate the complex characteristics of these children, and particularly emphasized the constant facial abnormalities and cognitive and behavioral problems. In 1978, in an important review on the subject, Clarren and Smith asserted that alcohol abuse during pregnancy was probably the leading cause of mental retardation in the Western world, redefining the series of malformations and behavioral alterations that were called Funny Looking Kinds (bizarre-types) and considering the mental retardation as the main neurocognitive problem of these children \[[@r33]\]. The extent of damage induced by ethanol can vary due to the timing, frequency and volume of alcohol consumed, as well as the genetic and metabolic features of the mother, leading to a wide variability in severity symptoms. The disorders resulting from prenatal alcohol exposure, together identified as Fetal Alcohol Spectrum Disorders (FASD) \[[@r34]-[@r37]\], include a range of categories, referred by the Institute of Medicine (IOM) \[[@r38]\] as Alcohol Related Neurodevelopmental Disorders (ARND), Alcohol Related Birth Defects (ARBD), the partial Fetal Alcohol Syndrome (pFAS) and finally, the FAS, which is the most severe form.

In adults, the ethanol toxicity has been demonstrated in several organs, but those mostly affected seem to be the brain and the liver. As for the fetal exposure, the primarily affected organ is the brain \[[@r39]\]. At the time, the mechanisms of ethanol toxicity on the fetus have not been fully elucidated and several hypotheses have been proposed. In this regard, in 1981, Henderson and colleagues in their studies on the mechanisms leading to FAS focused on the mutagenicity of ethanol \[[@r40]\]. Ten years later, Michaelis wrote a review that discussed various cellular and molecular mechanisms including the disruption of placental transport of nutrients and the inhibition of protein synthesis on growth and maturation; the development of hypoxia and changes in the control of vascular tone; interactions between hypoxic conditions and neurotransmitter-activated mechanisms in the production of cellular damage in developing neurons as well as abnormalities in calcium-handling mechanisms and their effects on neuronal migration and differentiation \[[@r41]\]. More recently, another research group has sought to shed light on how ethanol affects brain maturation demonstrating the activation of a widespread neuronal death during the development of rat forebrain consequent to N-methyl-D aspartate (NMDA)-glutamate receptor blockage and activation of GABA-A receptors \[[@r42]\]. It should be emphasized that the excitatory amino acids may influence the processes of neuronal differentiation and synaptogenesis, may modulate the organization of neural circuits and may timely regulate biochemical events related to the phenomenon of neuronal plasticity. Therefore, it is conceivable that a reduction of glutamatergic transmission, caused by ethanol exposure at critical stages of development, plays a key role in determining the neurotoxic effects of this substance abuse.

Other alcohol teratogenic mechanisms proposed in recent years are reduced prostaglandin synthesis, reduced transportation of placental glucose, amino acids and hypoxia, reduced synthesis of insulin-like growth factor, alterations of IL-1 mediated cellular transmission, down regulation of functional networks of developmental genes (Shh, Pax6), inhibition of DNA-methyltransferase and alterations at the neurotrophins level (Fig. **[1](#F1){ref-type="fig"}**). Furthermore, during the last 20 years, among the mechanisms responsible for the alcohol toxicity great interest it has been given to oxidative stress \[[@r43]\] and in those compounds having antioxidant properties \[[@r39], [@r44]-[@r47]\]. The ethanol-induced cell damage is probably the sum of all the mechanisms described above and probably also of others that have not yet been uncovered.

It seems now widely recognized that the adverse effects of alcohol are not only produced by the ethanol molecule itself, but may depend also on the action of ethanol metabolites/products within the central nervous system (CNS) \[[@r48]-[@r51]\]. The first metabolite product of alcohol is the acetaldehyde, an extremely toxic molecule that is produced by the partial oxidation of ethanol through several non-enzymatic and enzymatic mechanisms, including alcohol dehydrogenase (ADH), cytochrome *P*4502E1 (CYP2E1) and the catalase H~2~O~2~ system \[[@r50]\]. As for FAS, it is not well known whether alcohol itself or one or more of its metabolites is the primary cause of its onset \[[@r40]\]. Because of the kinetics of amniotic fluid circulation and because of the absence of enzymes necessary for ethanol biotransformation in the embryo, the amniotic fluid acts as a reservoir for unchanged alcohol and acetaldehyde. Indeed, ethanol and its teratogenic metabolite acetaldehyde freely cross the placenta, and accumulate in fetal blood at concentrations similar to those found in maternal blood \[[@r52]-[@r54]\]. Thus, the fetus is exposed to both compounds long after they have been metabolized from the maternal organism \[[@r55]\].

An important contribution in the study of prenatal ethanol toxicity has been given by findings from animal models, in order to clarify the cellular and biochemical mechanisms as well as the consequences of early developmental ethanol exposure \[[@r13], [@r16], [@r56]\].

3. Maternal Alcohol Exposure {#sec3}
============================

A number of studies from our and other groups showed that ethanol exposure in mice during pregnancy considerably affects NGF and BDNF synthesis and release \[[@r13], [@r14], [@r16], [@r25], [@r57]-[@r59]\]. The main element that exposes the fetus to the teratogenic risk of alcohol is the reduced ability of women to metabolize this substance. Women, at the same alcohol amounts ingested, have a blood alcohol concentration (BAC) of up to 3-4 times higher than that of men. Moreover, women were more likely than men to report drink problems at the same level of alcohol consumption. Compared to men, over the same timeframe and with comparable alcohol use, women have a 50 to 100 percent higher death rate due to suicides, accidents, and health problems \[[@r60]\] (web site: <https://pubs.niaaa.nih.gov/publications/brochurewomen/Woman_English.pdf>), experience a higher incidence of cardiomyopathy and liver diseases \[[@r61], [@r62]\] and show enhanced motor and cognitive impairments following exposure to alcohol \[[@r63]-[@r65]\].

This gender difference, leading to potentiated women vulnerability to the alcohol effects, is physiological and it is thought to be mainly due to differences in body water content, enzymatic activity of ADH and sex hormone, between men and women \[[@r66]-[@r69]\]. As for the enzymatic activity of ADH, it has been demonstrated that it varies with ages, in particular, in normal male drinkers it is highest between 20 and 40 years and then decreases until be halved between 61 and 80 years. By contrast, in women the gastric ADH activity is very low between 20 and 40 years, reaches its peak between 40 and 60 and then decreases similarly to what happens in men \[[@r70]\]. Therefore, the critical period corresponds to the age group between 20 and 40 years, when the gender differences are more significant, women are metabolically more exposed to the alcohol effects and above all they are of childbearing age, so, the risk of exposure and fetal damage increases. The increased concentration of ethanol in the blood stream leads to the saturation of the enzymes involved in its metabolism. Ethanol quickly reaches the mother\'s bloodstream and, by facilitated diffusion, crosses the placental barrier and, from there, is distributed to fetal circulatory system. Within minutes after taking an alcoholic drink, the alcohol concentration in the blood of the fetus and in the amniotic fluid is similar to that of the mother \[[@r71], [@r72]\]. Unlike the adult, however, the fetus cannot metabolize alcohol because devoid of enzymes responsible for this purpose. In this context, is also necessary to consider the presence, at an individual level, of genetic variants affecting genes involved in alcohol metabolism (alcohol dehydrogenase and aldehyde dehydrogenase) \[[@r73]\].

A still growing number of studies from animal models demonstrated that ethanol exposure in mice during pregnancy has marked effects on the NGF and BDNF synthesis and release \[[@r15], [@r74]-[@r76]\]. These findings suggest that the abnormal development of the central and peripheral nervous system may be due, at least partly, to growth factors deregulation (Fig. **[2](#F2){ref-type="fig"}**). Studies have provided evidence that BDNF and other neurotrophins appear to be crucial for the neurogenesis in the hippocampus and other neuronal plasticity systems \[[@r77], [@r78]\] and that alcohol exposure can affect NGF and BDNF expression in several brain areas \[[@r79]-[@r83]\]. Developmental models have demonstrated that prenatal ethanol exposure significantly potentiate NGF levels in cortex/striatum of one day old rats, while levels return to baseline after 10 days \[[@r84], [@r85]\]. Moreover, prenatal ethanol exposure induces an increase in TrkA receptor levels in the cortex of male and female pups on one day old rats \[[@r86]\]. Prenatal alcohol exposure has also been shown to alter BDNF signalling in several brain regions, for example decreasing the levels of BDNF protein in the medial prefrontal cortex \[[@r79]\]. It was also demonstrated that ethanol exposure from gestational days 5 to 20 induces a reduction in BDNF protein and mRNA in the rat cortex and hippocampus, when assessed on postnatal days 7-8 \[[@r58]\]. Prenatal ethanol exposure alters also TrkB receptor levels, inhibiting the phosphorylation of TrkB and leaving the total TrkB level unchanged \[[@r58]\]. Another study showed that alcohol exposure in utero produces a decrease in TrkB levels in the hippocampus of male rat pups on postnatal day 1, an increase in TrkB in the cortex, while no changes in TrkB levels in the septum and cerebellum were found \[[@r86]\]. The same authors have shown a different pattern of changes in female pups, demonstrating a decrease in TrkB levels in the septum, a consistent elevation in the cortex and no changes in hippocampus \[[@r86]\]. In general, the variety of changes in BDNF signalling highlighted by several studies is related to brain region, sex of animal and time point \[[@r3]\].

Our research group, in a longitudinal analysis using a mouse model of prenatal ethanol exposure, investigated the short- and long-term consequences of prenatal alcohol consumption in the offspring during adolescence, adulthood and aging \[[@r13]-[@r16]\]. We analyzed cognitive and behavioral parameters, the levels of NGF and BDNF in the offspring's brain, including hippocampus and cortex, and the choline acetyltransferase (ChAT) immunopositivity. Data showed that early administration of ethanol induces profound alterations in the levels of NGF and BDNF in the hippocampus and other brain areas of the offspring, associated to altered cognition and emotional behavior and with impaired ChAT immunopositivity in the septum and nuclei basalis. The biggest changes have been reported in adult mice (90 days). NGF and BDNF disruptions were also discovered in other organs as the liver, kidneys, testis and thyroid.

An interesting aspect of our work was the comparison between the effects of prenatal exposure to ethanol *per se* compared to red wine (at the same ethanol concentration). Data obtained in this investigation showed that animals early exposed to red wine, although the amount of ethanol was comparable, did not display the same alteration in the brain morphology and function and in cognitive performance of those mice exposed to ethanol only, suggesting that compounds contained into the red wine could counteract some deleterious effects of alcohol, acting as "protective" molecules. However, it should be also noted that no protection was observed for other ethanol target organs as liver, testis and adrenal glands.

Nevertheless, data emerged by our studies comparing the consequences of early exposure to ethanol and red wine (at the same ethanol concentration) during different stages of development in animal models should not be interpreted as encouraging women to consume red wine, before or during pregnancy and/or lactation. Among these "protective" compounds, we suggested that the main candidates could be antioxidant compounds as the polyphenols \[[@r44]-[@r47], [@r87]\]. The potential protective effect of the polyphenolic content of the red wine in our mouse model is in agreement with animal studies showing that the administration of antioxidants may contribute to reducing ethanol-induced fetal damage \[[@r88]\]. Particular attention is now focused by the scientific community on these molecules present in plants and plant-derived products due to their several effects in various pathological states \[[@r89]\]. Indeed, they are able to modulate and control oxidative stress, inflammation, apoptosis, mitochondrial dysfunction, all mechanisms which contribute to the etiology of neurodegenerative diseases \[[@r90]\], including ethanol-induced brain diseases \[[@r47]\]. Moreover, they demonstrated to potentiate neurotrophins' action and this is probably an additional protective mechanism of these compounds \[[@r87]\]. Quite interestingly, red wine drinking associated with an enriched diet with fresh vegetables and fruits, known to contain high amounts of antioxidant polyphenols, by women during pregnancy could explain the low incidence of FAS-related problems in some mediterranean areas, although, with the contemporary presence of FASD children \[[@r91], [@r92]\] if compared to other countries \[[@r93]\]. Further findings showed that in humans affected by alcohol use disorders olive polyphenols may modulate and counteract BDNF serum elevation, but not NGF, due to alcohol withdrawal \[[@r21], [@r94]\].

4. Paternal Alcohol Exposure {#sec4}
============================

Also the role of the paternal alcohol exposure prior to mating received special attention (Fig. **[2](#F2){ref-type="fig"}**). Previous data reported that about 75% of children with FASD had heavy drinkers or alcoholic biological fathers \[[@r95]\], suggesting that the anomalies in the offspring, generally attributed to the teratogenic effect of maternal drinking, may also be due to or exacerbated by the paternal alcohol consumption. Data showed that offspring sired by alcoholic fathers exhibit difficulty in a variety of learning tasks, as passive avoidance \[[@r96]\], and that paternal alcohol exposure seems to induce an increase in major malformations or average fetal or birth weights in animal offspring \[[@r95]\]. A number of studies from rodent models showed that paternal alcohol exposure prior to mating might induce developmental abnormalities, as changes in organs weight, including brain \[[@r97], [@r98]\], reduction in testosterone levels \[[@r99]\] and thickening of cortical layers \[[@r100]\], and also behavioral abnormalities as altered spatial learning performance \[[@r101]\] and disrupted immobility in a forced swim test \[[@r102]\]. In the context of these studies, our research group investigated whether or not paternal alcohol exposure may disrupt NGF and/or BDNF affecting EtOH preference/rewarding properties in the male offspring. We found changes in NGF and BDNF expression in the brain and an increase in ethanol-elicited preference in the offspring \[[@r103]\]. In another study it was found that male offspring sired by adult male mice exposed to chronic intermittent vapour ethanol prior to mating show attenuated ethanol drinking behavior, increased sensitivity to the anxiolytic effects of ethanol, and increased BDNF gene expression in the ventral tegmental area \[[@r104]\]. More recently, the same research group, in a study on adult male mice exposed to chronic intermittent vapour ethanol or control conditions for 5 weeks before being mated with ethanol-naïve females to produce ethanol- and control-sired offspring, investigated whether paternal ethanol exposure could impact stress responsivity in the offspring. They demonstrated that paternal ethanol exposure confers stress hypo-responsivity to male offspring, at both endocrine and behavioral levels \[[@r105]\]. In particular, in this study, authors showed reduced plasma Corticosterone in response to acute restraint stress and resistance to stress-induced excessive fluid intake. Indeed, using a stress-evoked ethanol-drinking assay, authors found increased total fluid intake in response to stress in the control-sired male offspring while ethanol-sired offspring seemed to be resistant to this stress-induced phenotype \[[@r105]\]. Liang and colleagues hypothesized also a possible alteration, induced by chronic paternal ethanol exposure, on the methylation of imprinted genes in sire spermatozoa that could also be inherited by the offspring, giving rise to developmental disorders \[[@r106]\].

Recently, in addition to animal studies strongly supporting the contribution of paternal alcoholic habits, robust evidence in humans are becoming increasingly available. Zuccolo and colleagues, using data from 68,244 mothers, fathers and children from the Norwegian Mother and Child Cohort Study (MoBa), investigated the association of maternal and paternal alcohol drinking before and early in pregnancy with infant head circumference. Researchers demonstrated higher probability of microcephaly at birth for higher paternal alcohol consumption before pregnancy, but not for maternal consumption \[[@r107], [@r108]\].

5. NEUROTROPHINS IN THE Strategies for FAS/FASD intervention and treatment {#sec5}
==========================================================================

Alcohol consumption before conception and during pregnancy and lactation is among the most common preventable causes of mental retardation in the Western world. However, despite this, women and men continue to drink before and during pregnancy, making necessary the study of the mechanisms that contribute to alcohol's harmful fetal effects and then the development of effective treatments and interventions for FAS and FASD as well as of reliable preventive and diagnostic systems \[[@r109]\].

Since, at the present time, a safe threshold of consumption can not be estimated, the only feasible recommendation for pregnant women is the total abstention from alcohol use before and during pregnancy \[[@r110], [@r111]\]. In addition, it is now known that fathers should also refrain from drinking before conception, being currently known a direct paternal impact on changes affecting the progeny, probably due to epigenetic mechanisms \[[@r103]\]. In addition to the preventive approach, it may be useful to identify prognostic markers of prenatal alcohol exposure in order to provide effective early intervention systems. The difficulty of establishing a correct estimation of FASD incidence is demonstrated by several studies reporting discordant epidemiological data. Popova and colleagues \[[@r112]\] reviewing international literature from 1984, tried to establish an estimation of the global, regional, and national prevalence of alcohol consumption causing FASD. According to these authors, Italy is among the five countries worldwide with the highest prevalence of FAS per 10,000 people. By contrast, Pichini and colleagues seem to disagree with this estimation \[[@r113]\], underlining that Italy is the country with the lowest annual consumption of alcohol per capita, lower percentage of women with alcohol use disorders, dependence and the highest number of female lifetime abstainers. Published data from an observational, cross-sectional case-control study \[[@r92]\], on 976 children from an area of small towns in central Italy, show a FAS rate between 4 and 12 per 1000 people in 2011. The large number of studies reflects the currently unreliable estimation of prevalence of FAS/FASD also due to the presence of several factors that could lead to overestimation or underestimation of the data \[[@r114]\].

CONCLUSION
==========

Unfortunately, establishing the mother's alcohol consumption is rather difficult as the admission of alcohol use before and during pregnancy may be accompanied by heavy guilt feelings \[[@r110], [@r115]\]. This means that for assessing the real mother's alcohol consumption is necessary an approach based not only on specific screening questionaries but also on objective measurements of the real presence of alcohol in the body. The use of direct and non-direct biomarkers of alcohol use as Carbohydrate Deficient Transferrin, Ethylglucuronide, Fatty Acid Ethyl Esters, Ethylsulfate and Phosphatidylethanol can help to overcome this problem \[[@r109], [@r116], [@r117]\]. In particular, the measurement of EtG in several biological matrices, including neonatal and maternal hair, neonatal meconium and maternal urine, is currently receiving increasing interest. Furthermore, since NGF and BDNF levels are known to be disrupted in the brain and periphery during acute/chronic and prenatal alcohol consumption \[[@r15], [@r21], [@r83], [@r94]\], it could be predicted that their changes in the meconium, cord blood or in the mother/infant serum could be proposed as additional markers of FASD and/or other alcohol-related diseases and current investigations are in progress. Early detection of prenatal ethanol exposure would allow early detection of neonatal outcomes and the possible occurrence of FASD as well as early intervention with an appropriate therapeutic approach.

As for the induction of alcohol-related deficits, it has been suggested an important link between alcohol and neurotrophins, thus neuropharmacological approaches based on the increase in neurotrophin availability promoting neuroprotection against alcohol toxicity could provide a possible support. Indeed, some therapeutic interventions naturally enhancing neurotrophin brain expression may further represent a valuable system to make the brain potentially self healing \[[@r3]\]. Among these interventions learning experiences, exercise, environmental stimulation, dietary restriction \[[@r118]-[@r121]\] and polyphenol-rich diet \[[@r46], [@r122]\] can support the brain to potentiate its own defences.
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